Fig. 4From: Pre-therapeutic lymphocytopenia: a new prognostic factor for failure of endovesical BCG-immunotherapy in non-muscle invasive bladder cancerBCG-therapy resistance-free survival in the Lymphocyte > 1.67 × 109/L group vs. the Lymphocyte ≤ 1.67 × 109/L group by a Log-Rank modelBack to article page